Aeterna Zentaris Revenue and Competitors
Estimated Revenue & Valuation
- Aeterna Zentaris's estimated annual revenue is currently $1.7M per year.
- Aeterna Zentaris's estimated revenue per employee is $41,463
- Aeterna Zentaris's total funding is $82.4M.
Employee Data
- Aeterna Zentaris has 41 Employees.
- Aeterna Zentaris grew their employee count by 0% last year.
Aeterna Zentaris's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Coordonnatrice - relations avec les investisseurs | Reveal Email/Phone |
2 | Director Communications | Reveal Email/Phone |
3 | Chair, Board Directors | Reveal Email/Phone |
Aeterna Zentaris Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7.8M | 39 | 0% | N/A | N/A |
#2 | $1.7M | 41 | 0% | $82.4M | N/A |
#3 | $102.7M | 511 | 1% | N/A | N/A |
#4 | $7M | 35 | 6% | N/A | N/A |
#5 | $12.3M | 61 | -12% | N/A | N/A |
#6 | $410.8M | 2044 | -7% | N/A | N/A |
#7 | $48.6M | 242 | 7% | N/A | N/A |
#8 | $14.7M | 73 | 0% | N/A | N/A |
#9 | $9M | 45 | -12% | N/A | N/A |
#10 | $10.7M | 53 | 4% | N/A | N/A |
What Is Aeterna Zentaris?
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women's health. The companys product pipeline includes MACRILEN, which completed the Phase 2 trial for use in the diagnosis of adult growth hormone deficiency; and zoptarelin doxorubicin, which is in Phase 3 clinical study zoptarelin doxorubicin in endometrial cancer (ZoptEC) of the compound in women with advanced, recurrent, or metastatic endometrial cancer. It is also developing two oncology compounds, including an Erk inhibitor and luteinizing hormone-releasing hormone-disorazol Z product candidates, which are in pre-clinical development. Aeterna Zentaris Inc. was founded in 1991 and is headquartered in Quebec City, Canada.
keywords:N/A
$82.4M
Total Funding
41
Number of Employees
$1.7M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Aeterna Zentaris News
Aeterna Zentaris is a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and...
Aeterna Zentaris is a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and...
Aeterna Zentaris is a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and...
Other Companies in Summerville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 41 | 14% | N/A |
#2 | $8.2M | 42 | 8% | N/A |
#3 | $11M | 43 | 8% | N/A |
#4 | $8M | 44 | 5% | N/A |
#5 | N/A | 45 | 150% | N/A |